Rallybio Corporaton (RLYB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 858 | 636 | 0 | 0 | 0 |
| Gross Profit | 858 | 636 | N/A | N/A | N/A |
| Operating Expenses | 33,922 | 61,132 | 78,932 | 67,884 | 45,648 |
| Operating Income | -33,064 | -60,496 | -78,932 | -67,884 | -45,648 |
| Interest Expense | 0 | 0 | 0 | 0 | 10 |
| Other Income | 24,960 | 4,960 | 6,409 | 2,305 | 150 |
| Pre-tax Income | -8,104 | -55,536 | -72,523 | -65,579 | -45,508 |
| Income Tax | N/A | N/A | N/A | N/A | 1,505 |
| Net Income Continuous | -8,978 | -57,775 | -74,564 | -66,654 | -47,013 |
| Net Income | $-8,978 | $-57,775 | $-74,564 | $-66,654 | $-47,013 |
| EPS Basic Total Ops | -1.59 | -10.61 | -14.72 | -16.72 | -14.72 |
| EPS Basic Continuous Ops | -1.59 | -10.61 | -14.75 | -16.76 | -14.74 |
| EPS Diluted Total Ops | -1.59 | -10.61 | -14.72 | -16.72 | -14.72 |
| EPS Diluted Continuous Ops | -1.59 | -10.61 | -14.75 | -16.76 | -14.74 |
| EPS Diluted Before Non-Recurring Items | -5.64 | -10.64 | -14.72 | -16.72 | -14.72 |
| EBITDA(a) | $-33,545 | $-61,977 | $-81,871 | $-68,152 | $-45,539 |